More community trust. Less forced connections. A recent UK survey found that only 14% percent of users mostly or completely trust lifestyle influencers, while 51% completely or mostly trust patient influencers. When it comes to branded pharma products, the survey was even more positive for patient influencers: 85% said they would be very or [...]
COVID-19 has sparked a flurry of research and discoveries that are being made at an unprecedented rate – but patient engagement cannot and should not be left behind in the rush. SARS-CoV-2 has demonstrated both the strengths and the weaknesses of the life sciences ecosystem, and it is now up to the sector to [...]
Over the past few years, our digital world has moulded a new kind of patient – engaged and empowered individuals who want to be actively involved in their health journey. With access to different treatment paths and complementary approaches based on location, physician, insurance, funds and more, therapies are becoming more personalized than ever [...]
The number of clinical research programs undertaken by the major pharma players has now fallen by as much as 70% in the last ten years. The global pharmaceutical industry has spent well over a trillion dollars on research and development in the last ten years, and analysts expect annual investment levels to grow by [...]
Aug 22, 2019 By Allie Nawrat Pharmaceutical Technology NASA’s TRISH has funded innovative projects seeking to better protect astronauts' health during deep space missions. Two of the six projects focus on ‘just-in-time’ medications, which allow drugs to be manufactured on-demand and on-board the spacecraft. Allie Nawrat talks to the TRISH scientist Dr Emmanuel Urquieta [...]
Aug 22, 2019 By George Underwood Pharmaphorum George Underwood looks at the rapid growth of patient centricity over the last few years and considers what pharma’s next steps should be to enhance patient engagement. I still consider myself a relative newbie to the pharma industry, having only started seriously covering the sector five years ago. [...]